Opthea Limited American Depositary Shares is a biotechnology company specializing in the development of novel therapeutics for eye diseases. With a focus on treating diseases such as wet age-related macular degeneration and diabetic macular edema, Opthea is committed to creating innovative solutions to improve patients’ quality of life.
